Endovastec™ Presents Flagship Products at CICE 2022

Recently, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”) held a seminar at the International Congress of Endovascular Surgery (Congresso International de Cirurgia Endovascular, CICE 2022) in Brazil, engaging local and global experts.

Endovastec™ Castor™ Debuted at the First eCICE Conference in Brazil

​São Paulo, Brazil, 30 October 2020 — The first virtual International Congress of Endovascular Surgery (eCongresso Internacional de Cirurgia Endovascular (eCICE)) kicked off as an online event from 7 – 8th September, 2020. As an influential conference in Latin America in the field of vascular surgery, the congress brought together vascular surgeons from around the world to showcase recent academic insights and developments in several cutting-edge application areas of endovascular treatment. Castor™ Branched Aortic Stent-Graft System (the “Castor™ Stent”), the world’s first stent system of the kind developed by Shanghai MicroPort Endovascular MedTech(Group) Co., Ltd. (“Endovastec™”), was launched on eCICE's live case demonstration.

Endovastec™ Holds Virtual Launch Meeting for Fontus™ Branched Surgical Stent Graft System

Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently hosted a product launch event titled “Elephant trunk for the heart: revival of the classic” for its Fontus™ Branched Surgical Stent Graft System (Fontus™), which was held back-to-back with a seminar on the stented elephant trunk procedure. Twenty-one experts from 17 hospitals gathered virtually to share clinical data and information related to the application of Fontus™, which attracted the attendance of over 5,000 viewers online.